Target intelligence / Profile preview

3-Nitrotyrosine (3-NT)

Target
3-NT
Molecular classification
Modified amino acid, Non-proteinogenic amino acid [3, 6], Oxidative stress biomarker [11], Post-translational modification (PTM) product [15]
01

Overview

3-Nitrotyrosine is a modified amino acid formed via the nitration of tyrosine residues in proteins, a process primarily mediated by reactive nitrogen species such as the peroxynitrite anion and nitrogen dioxide [1, 4]. It serves as a chemically stable and prominent biological footprint of nitrosative stress and chronic inflammation [11, 12]. Although it is not a traditional therapeutic target (such as an enzyme or receptor), its accumulation is a hallmark of diverse pathological conditions, including neurodegenerative diseases like Alzheimer's and Parkinson's, cardiovascular disorders, and autoimmune conditions [2, 7, 8]. The presence of 3-nitrotyrosine can significantly alter the biochemical properties of proteins, leading to inhibited enzymatic activity, altered protein-protein interactions, and the induction of pro-apoptotic pathways [15, 17]. In clinical and pharmaceutical research, 3-nitrotyrosine is extensively utilized as a biomarker to evaluate the efficacy of antioxidant and anti-inflammatory drug candidates in reducing oxidative damage [1, 8].

Other names
3-Nitro-L-tyrosineNitrotyrosineL-Tyrosine, 3-nitro-3-Mononitrotyrosine
02

Mechanism of action

Not applicable as a therapeutic target; 3-nitrotyrosine serves as a diagnostic biomarker and a surrogate indicator of nitrative damage in tissues [1, 11].

03

Biological functions

Biomarker of nitrosative stress [1, 11]Indicator of reactive nitrogen species (RNS) activity [4, 8]Inducer of protein conformational changes and dysfunction [1, 15]Promoter of cell death signaling [17]Neoantigen for autoantibody production [19]
04

Disease associations

Neurodegenerative disease (Alzheimer's, Parkinson's, ALS) [1, 2]Cardiovascular disease (Atherosclerosis, Myocardial infarction) [7, 8]Inflammation (Rheumatoid arthritis, Sepsis) [8, 19]Diabetes [8]Cancer [6]Autoimmune disease (Systemic lupus erythematosus) [11, 19]
05

Safety considerations

Non-specificity as it is elevated across multiple distinct inflammatory diseases [8]Analytical challenges in absolute quantification [1, 16]Irreversibility of the modification under most biological conditions [15]
06

Biomarkers

3-Nitrotyrosine (as a marker of nitrosative stress)Peroxynitrite levelsNitrated protein levels (e.g., nitrated fibrinogen, nitrated alpha-synuclein)

Beyond the preview

Go deeper on 3-Nitrotyrosine (3-NT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3-Nitrotyrosine (3-NT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call